 James Falko
Concepts (427)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperlipoproteinemia Type I | 1 | 2018 | 7 | 0.610 |
Why?
| | Hyperlipidemias | 8 | 2006 | 126 | 0.610 |
Why?
| | Alcohol Abstinence | 1 | 2018 | 13 | 0.610 |
Why?
| | Plasmapheresis | 1 | 2018 | 23 | 0.600 |
Why?
| | Diet, Fat-Restricted | 1 | 2018 | 80 | 0.590 |
Why?
| | Diabetic Angiopathies | 4 | 2005 | 261 | 0.500 |
Why?
| | Anticholesteremic Agents | 4 | 2012 | 150 | 0.500 |
Why?
| | Diabetic Neuropathies | 2 | 2005 | 96 | 0.450 |
Why?
| | Hyperlipoproteinemia Type II | 3 | 2016 | 34 | 0.430 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 339 | 0.410 |
Why?
| | Lipoproteins | 10 | 1997 | 171 | 0.360 |
Why?
| | Hypothyroidism | 4 | 2018 | 70 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 12 | 2005 | 2441 | 0.320 |
Why?
| | Cardiovascular Diseases | 3 | 2012 | 2004 | 0.300 |
Why?
| | Cholesterol, LDL | 9 | 2012 | 358 | 0.290 |
Why?
| | Lipoproteins, LDL | 11 | 1997 | 127 | 0.280 |
Why?
| | Hyperthyroidism | 8 | 1997 | 28 | 0.280 |
Why?
| | Hypolipidemic Agents | 3 | 2006 | 92 | 0.270 |
Why?
| | Fenofibrate | 2 | 2003 | 31 | 0.260 |
Why?
| | Lipoproteins, HDL | 11 | 2008 | 85 | 0.240 |
Why?
| | Triglycerides | 12 | 2008 | 527 | 0.240 |
Why?
| | Blood Component Removal | 2 | 2016 | 26 | 0.220 |
Why?
| | Pancreatitis | 5 | 2018 | 129 | 0.220 |
Why?
| | Rhabdomyolysis | 1 | 2003 | 22 | 0.210 |
Why?
| | Dietary Fats | 5 | 1996 | 301 | 0.210 |
Why?
| | Insulin | 16 | 1991 | 2326 | 0.210 |
Why?
| | Dyslipidemias | 1 | 2005 | 177 | 0.210 |
Why?
| | Diagnosis, Differential | 8 | 2018 | 1434 | 0.200 |
Why?
| | Hypertriglyceridemia | 2 | 2018 | 39 | 0.200 |
Why?
| | Blood Glucose | 20 | 2008 | 2097 | 0.200 |
Why?
| | Cholesterol, HDL | 8 | 2005 | 205 | 0.200 |
Why?
| | Cholesterol | 12 | 2006 | 412 | 0.170 |
Why?
| | Apolipoproteins | 6 | 1984 | 38 | 0.160 |
Why?
| | Xanthomatosis | 2 | 2018 | 11 | 0.160 |
Why?
| | Thyroid Neoplasms | 6 | 1998 | 310 | 0.160 |
Why?
| | Hepatomegaly | 1 | 2018 | 5 | 0.150 |
Why?
| | Hyperlipoproteinemia Type IV | 3 | 1996 | 3 | 0.150 |
Why?
| | Splenomegaly | 1 | 2018 | 15 | 0.150 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 28 | 0.150 |
Why?
| | Lipoprotein Lipase | 1 | 2018 | 59 | 0.150 |
Why?
| | Dietary Carbohydrates | 4 | 1986 | 151 | 0.150 |
Why?
| | Humans | 90 | 2018 | 129652 | 0.150 |
Why?
| | Carcinoma, Papillary | 1 | 1998 | 77 | 0.140 |
Why?
| | Thyroid Nodule | 1 | 1998 | 55 | 0.140 |
Why?
| | Lipoproteins, VLDL | 7 | 1984 | 25 | 0.140 |
Why?
| | Endocrinology | 1 | 2018 | 75 | 0.140 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1001 | 0.140 |
Why?
| | Abdominal Pain | 1 | 2018 | 144 | 0.140 |
Why?
| | Glyburide | 3 | 1985 | 35 | 0.130 |
Why?
| | Gastrointestinal Hormones | 4 | 1982 | 8 | 0.130 |
Why?
| | Arteriosclerosis | 4 | 1997 | 88 | 0.130 |
Why?
| | Adenoma, Islet Cell | 3 | 1984 | 10 | 0.130 |
Why?
| | Insulinoma | 3 | 1984 | 30 | 0.130 |
Why?
| | Genetic Therapy | 1 | 2018 | 292 | 0.130 |
Why?
| | C-Peptide | 7 | 1986 | 163 | 0.130 |
Why?
| | Cost of Illness | 1 | 2018 | 278 | 0.130 |
Why?
| | Lipids | 6 | 2006 | 625 | 0.130 |
Why?
| | Gastric Inhibitory Polypeptide | 4 | 1986 | 23 | 0.130 |
Why?
| | Lipoprotein(a) | 1 | 2016 | 67 | 0.120 |
Why?
| | Recurrence | 1 | 2018 | 1007 | 0.120 |
Why?
| | Female | 69 | 2016 | 68777 | 0.120 |
Why?
| | Middle Aged | 42 | 2016 | 31155 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 1996 | 138 | 0.110 |
Why?
| | Niacin | 2 | 2005 | 19 | 0.110 |
Why?
| | Obesity | 7 | 2010 | 2883 | 0.110 |
Why?
| | Sucrose | 3 | 1986 | 99 | 0.110 |
Why?
| | Glucose Tolerance Test | 5 | 1987 | 356 | 0.100 |
Why?
| | Alcoholism | 2 | 2018 | 766 | 0.100 |
Why?
| | Receptors, LDL | 1 | 2012 | 47 | 0.100 |
Why?
| | Hyperparathyroidism | 3 | 1984 | 11 | 0.100 |
Why?
| | Thrombosis | 1 | 2016 | 343 | 0.100 |
Why?
| | Glucose | 7 | 1986 | 1003 | 0.100 |
Why?
| | Plaque, Atherosclerotic | 1 | 2012 | 55 | 0.100 |
Why?
| | Adult | 47 | 2008 | 35577 | 0.100 |
Why?
| | Drug Design | 1 | 2012 | 156 | 0.090 |
Why?
| | Pheochromocytoma | 2 | 1990 | 57 | 0.090 |
Why?
| | Adrenal Gland Neoplasms | 2 | 1990 | 84 | 0.090 |
Why?
| | Male | 51 | 2010 | 63682 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 1996 | 493 | 0.090 |
Why?
| | Hyperaldosteronism | 1 | 1990 | 8 | 0.090 |
Why?
| | Hypercalcemia | 2 | 1984 | 21 | 0.090 |
Why?
| | Splenic Neoplasms | 1 | 1990 | 3 | 0.090 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 1990 | 5 | 0.090 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 1990 | 37 | 0.090 |
Why?
| | Hyperlipoproteinemia Type III | 2 | 1980 | 3 | 0.080 |
Why?
| | Coronary Artery Disease | 2 | 2006 | 679 | 0.080 |
Why?
| | Pancreatic Neoplasms | 4 | 1984 | 882 | 0.080 |
Why?
| | Musculoskeletal Diseases | 1 | 2010 | 69 | 0.080 |
Why?
| | Age Factors | 3 | 2012 | 3144 | 0.080 |
Why?
| | Fructose | 3 | 1987 | 106 | 0.070 |
Why?
| | Lipid Metabolism | 3 | 2006 | 497 | 0.070 |
Why?
| | Diuretics | 2 | 1986 | 76 | 0.070 |
Why?
| | Physical Therapy Modalities | 1 | 2010 | 292 | 0.070 |
Why?
| | Indapamide | 1 | 1986 | 1 | 0.070 |
Why?
| | Metoclopramide | 1 | 1986 | 19 | 0.070 |
Why?
| | Apoproteins | 1 | 1986 | 13 | 0.070 |
Why?
| | Stomach Diseases | 1 | 1986 | 20 | 0.070 |
Why?
| | Quality of Life | 1 | 2018 | 2704 | 0.070 |
Why?
| | Optic Atrophy | 1 | 1986 | 10 | 0.070 |
Why?
| | Cyclosporins | 1 | 1986 | 77 | 0.060 |
Why?
| | Community Health Services | 1 | 2008 | 227 | 0.060 |
Why?
| | Hyponatremia | 1 | 1986 | 40 | 0.060 |
Why?
| | Shoes | 1 | 2005 | 18 | 0.060 |
Why?
| | Muscular Diseases | 1 | 1986 | 107 | 0.060 |
Why?
| | Diabetic Foot | 1 | 2005 | 25 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 1990 | 640 | 0.060 |
Why?
| | Heptanoic Acids | 1 | 2005 | 64 | 0.060 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 1979 | 247 | 0.060 |
Why?
| | Sulfonylurea Compounds | 1 | 1985 | 46 | 0.060 |
Why?
| | Medical History Taking | 1 | 2005 | 119 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2635 | 0.060 |
Why?
| | Deafness | 1 | 1986 | 80 | 0.060 |
Why?
| | Radionuclide Imaging | 6 | 1998 | 123 | 0.060 |
Why?
| | Weight Loss | 2 | 2010 | 734 | 0.060 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 1984 | 53 | 0.060 |
Why?
| | Ultrasonography | 2 | 1984 | 716 | 0.060 |
Why?
| | Pyrroles | 1 | 2005 | 202 | 0.060 |
Why?
| | Pain | 1 | 2010 | 789 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2005 | 224 | 0.050 |
Why?
| | Physical Examination | 1 | 2005 | 234 | 0.050 |
Why?
| | Iodine Radioisotopes | 3 | 1998 | 143 | 0.050 |
Why?
| | Clinical Trials as Topic | 2 | 2005 | 1004 | 0.050 |
Why?
| | Ezetimibe | 1 | 2003 | 25 | 0.050 |
Why?
| | Fish Oils | 1 | 2003 | 26 | 0.050 |
Why?
| | Azetidines | 1 | 2003 | 40 | 0.050 |
Why?
| | Time Factors | 8 | 2006 | 6556 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2005 | 401 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 1991 | 3628 | 0.050 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 1984 | 182 | 0.050 |
Why?
| | Coronary Disease | 1 | 2005 | 385 | 0.050 |
Why?
| | Furosemide | 2 | 1986 | 39 | 0.050 |
Why?
| | 1-Propanol | 1 | 1982 | 1 | 0.050 |
Why?
| | Heart Diseases | 1 | 2005 | 350 | 0.050 |
Why?
| | Osteoporosis | 1 | 1985 | 232 | 0.050 |
Why?
| | Particle Size | 1 | 2003 | 355 | 0.050 |
Why?
| | Aged | 13 | 2006 | 22104 | 0.050 |
Why?
| | Apolipoproteins C | 2 | 1982 | 6 | 0.050 |
Why?
| | Mutation | 1 | 2012 | 3717 | 0.050 |
Why?
| | Patient Care Team | 1 | 2006 | 605 | 0.050 |
Why?
| | Hypertension | 3 | 1986 | 1242 | 0.050 |
Why?
| | Exercise Therapy | 1 | 2005 | 412 | 0.050 |
Why?
| | Empty Sella Syndrome | 1 | 1981 | 1 | 0.050 |
Why?
| | Metrizamide | 1 | 1981 | 1 | 0.050 |
Why?
| | Copper | 2 | 1997 | 109 | 0.040 |
Why?
| | Hyperlipoproteinemia Type V | 1 | 1979 | 1 | 0.040 |
Why?
| | Hyperlipoproteinemias | 1 | 1979 | 7 | 0.040 |
Why?
| | Ethinyl Estradiol | 1 | 1979 | 17 | 0.040 |
Why?
| | Sodium Pertechnetate Tc 99m | 2 | 1998 | 6 | 0.040 |
Why?
| | Drug Therapy, Combination | 4 | 1991 | 1040 | 0.040 |
Why?
| | Calcium | 2 | 1984 | 1213 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 1986 | 672 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 430 | 0.040 |
Why?
| | Central Nervous System Diseases | 1 | 1979 | 68 | 0.040 |
Why?
| | Sodium Iodide | 1 | 1998 | 3 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 5 | 1993 | 2535 | 0.040 |
Why?
| | Medicine, Ayurvedic | 1 | 1997 | 1 | 0.040 |
Why?
| | Insulin Infusion Systems | 1 | 1982 | 363 | 0.040 |
Why?
| | Primary Health Care | 2 | 2006 | 1680 | 0.040 |
Why?
| | Pancreatic Juice | 1 | 1977 | 2 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 1998 | 168 | 0.040 |
Why?
| | Water-Electrolyte Balance | 1 | 1977 | 34 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 1997 | 151 | 0.030 |
Why?
| | Phytotherapy | 1 | 1997 | 79 | 0.030 |
Why?
| | Oxidation-Reduction | 2 | 1997 | 1033 | 0.030 |
Why?
| | Drug Resistance | 1 | 1997 | 166 | 0.030 |
Why?
| | Thyroid Gland | 3 | 1982 | 94 | 0.030 |
Why?
| | Acidosis, Renal Tubular | 1 | 1976 | 5 | 0.030 |
Why?
| | Diazoxide | 1 | 1977 | 23 | 0.030 |
Why?
| | Stomach | 2 | 1983 | 109 | 0.030 |
Why?
| | Oils | 2 | 1976 | 21 | 0.030 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 1996 | 6 | 0.030 |
Why?
| | Carcinoma, Medullary | 1 | 1996 | 14 | 0.030 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 1996 | 9 | 0.030 |
Why?
| | Proto-Oncogenes | 1 | 1996 | 29 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 1985 | 1220 | 0.030 |
Why?
| | Magnesium Deficiency | 1 | 1976 | 2 | 0.030 |
Why?
| | Polycythemia | 1 | 1976 | 22 | 0.030 |
Why?
| | Procainamide | 1 | 1975 | 6 | 0.030 |
Why?
| | Pituitary Neoplasms | 3 | 1982 | 184 | 0.030 |
Why?
| | Reference Values | 1 | 1997 | 793 | 0.030 |
Why?
| | Hypocalcemia | 1 | 1976 | 28 | 0.030 |
Why?
| | Body Mass Index | 3 | 2010 | 2273 | 0.030 |
Why?
| | Adolescent | 12 | 1998 | 20394 | 0.030 |
Why?
| | Bone Resorption | 1 | 1976 | 79 | 0.030 |
Why?
| | Pancreas | 1 | 1977 | 306 | 0.030 |
Why?
| | Anemia | 1 | 1976 | 160 | 0.030 |
Why?
| | Pancreatic Cyst | 1 | 1975 | 52 | 0.030 |
Why?
| | Graves Disease | 3 | 1985 | 35 | 0.030 |
Why?
| | Acute Kidney Injury | 1 | 1982 | 790 | 0.030 |
Why?
| | Antioxidants | 1 | 1997 | 559 | 0.030 |
Why?
| | Orbital Pseudotumor | 1 | 1993 | 3 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2002 | 1066 | 0.030 |
Why?
| | Hypopituitarism | 1 | 1993 | 16 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 1996 | 390 | 0.030 |
Why?
| | Cranial Nerve Diseases | 1 | 1993 | 41 | 0.030 |
Why?
| | Postpartum Period | 1 | 1996 | 332 | 0.030 |
Why?
| | Acute Disease | 4 | 2002 | 980 | 0.020 |
Why?
| | Animals | 3 | 2012 | 35361 | 0.020 |
Why?
| | Paralysis | 1 | 1993 | 69 | 0.020 |
Why?
| | Cholestasis | 1 | 1975 | 232 | 0.020 |
Why?
| | Fasting | 3 | 2006 | 267 | 0.020 |
Why?
| | Risk Factors | 4 | 2008 | 9765 | 0.020 |
Why?
| | Isoelectric Focusing | 3 | 1982 | 34 | 0.020 |
Why?
| | Thyrotropin | 2 | 1982 | 109 | 0.020 |
Why?
| | Cohort Studies | 3 | 2006 | 5420 | 0.020 |
Why?
| | Patient Education as Topic | 2 | 2006 | 743 | 0.020 |
Why?
| | Octreotide | 1 | 1991 | 27 | 0.020 |
Why?
| | Androgen-Insensitivity Syndrome | 1 | 1990 | 5 | 0.020 |
Why?
| | Sex Factors | 2 | 2006 | 1968 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1985 | 1876 | 0.020 |
Why?
| | Diet, Diabetic | 2 | 1987 | 35 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2010 | 49 | 0.020 |
Why?
| | Body Weight | 2 | 1986 | 940 | 0.020 |
Why?
| | Peptides | 1 | 1975 | 925 | 0.020 |
Why?
| | Hypoglycemia | 2 | 1984 | 427 | 0.020 |
Why?
| | Ketone Bodies | 2 | 1991 | 15 | 0.020 |
Why?
| | Secretory Rate | 2 | 1980 | 18 | 0.020 |
Why?
| | Myocardial Infarction | 1 | 1977 | 1022 | 0.020 |
Why?
| | Technetium | 2 | 1981 | 12 | 0.020 |
Why?
| | United States | 2 | 2005 | 13903 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2005 | 2012 | 0.020 |
Why?
| | Pregnancy | 2 | 1996 | 6402 | 0.020 |
Why?
| | Brain | 1 | 1981 | 2679 | 0.020 |
Why?
| | Thyroxine | 2 | 1981 | 62 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2008 | 10230 | 0.020 |
Why?
| | Adenoma | 2 | 1982 | 214 | 0.020 |
Why?
| | Ohio | 1 | 2008 | 152 | 0.020 |
Why?
| | Pain Measurement | 1 | 2010 | 506 | 0.020 |
Why?
| | Body Size | 1 | 2008 | 102 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1987 | 39 | 0.020 |
Why?
| | Suppositories | 1 | 1986 | 3 | 0.020 |
Why?
| | Pain Management | 1 | 2010 | 327 | 0.020 |
Why?
| | Intestinal Absorption | 2 | 1977 | 99 | 0.020 |
Why?
| | Gastric Emptying | 1 | 1986 | 40 | 0.020 |
Why?
| | Demeclocycline | 1 | 1986 | 3 | 0.020 |
Why?
| | Ticlopidine | 1 | 2006 | 54 | 0.020 |
Why?
| | Fitness Centers | 1 | 2006 | 4 | 0.020 |
Why?
| | Drug Administration Schedule | 2 | 2005 | 769 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 1986 | 62 | 0.020 |
Why?
| | Electrolytes | 1 | 1986 | 60 | 0.020 |
Why?
| | Carcinoembryonic Antigen | 1 | 1985 | 41 | 0.020 |
Why?
| | Premenstrual Syndrome | 1 | 1985 | 34 | 0.020 |
Why?
| | Atrophy | 1 | 1986 | 171 | 0.020 |
Why?
| | Decalcification, Pathologic | 1 | 1985 | 1 | 0.020 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1985 | 5 | 0.020 |
Why?
| | Fluorescein Angiography | 1 | 1986 | 143 | 0.020 |
Why?
| | Sodium Chloride | 1 | 1986 | 138 | 0.020 |
Why?
| | Anthropometry | 1 | 2006 | 204 | 0.020 |
Why?
| | Osteomalacia | 1 | 1985 | 5 | 0.020 |
Why?
| | Placebos | 1 | 1985 | 201 | 0.010 |
Why?
| | Lung Neoplasms | 2 | 1990 | 2344 | 0.010 |
Why?
| | Cost-Benefit Analysis | 2 | 1984 | 569 | 0.010 |
Why?
| | Blood Protein Electrophoresis | 1 | 1984 | 8 | 0.010 |
Why?
| | Retrospective Studies | 3 | 2008 | 14518 | 0.010 |
Why?
| | Pentamidine | 1 | 1984 | 4 | 0.010 |
Why?
| | Insulin Antagonists | 1 | 1984 | 8 | 0.010 |
Why?
| | Probability | 1 | 2005 | 306 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1996 | 5762 | 0.010 |
Why?
| | Amidines | 1 | 1984 | 16 | 0.010 |
Why?
| | Thyroid Diseases | 1 | 1984 | 35 | 0.010 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2006 | 321 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1984 | 368 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1990 | 964 | 0.010 |
Why?
| | Hemoglobins | 2 | 1976 | 339 | 0.010 |
Why?
| | Parathyroid Neoplasms | 1 | 1984 | 13 | 0.010 |
Why?
| | Patient Participation | 1 | 2008 | 414 | 0.010 |
Why?
| | Adrenal Gland Diseases | 1 | 1983 | 6 | 0.010 |
Why?
| | Palliative Care | 1 | 1990 | 725 | 0.010 |
Why?
| | Blood Proteins | 1 | 1985 | 242 | 0.010 |
Why?
| | Exercise Tolerance | 1 | 2005 | 273 | 0.010 |
Why?
| | Program Evaluation | 1 | 2008 | 875 | 0.010 |
Why?
| | Parathyroid Hormone | 1 | 1984 | 106 | 0.010 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2006 | 442 | 0.010 |
Why?
| | Chromatography | 1 | 1982 | 25 | 0.010 |
Why?
| | Nicotinic Acids | 1 | 1982 | 6 | 0.010 |
Why?
| | Abortion, Induced | 1 | 1984 | 101 | 0.010 |
Why?
| | Gastrins | 1 | 1982 | 9 | 0.010 |
Why?
| | Administration, Oral | 2 | 1984 | 786 | 0.010 |
Why?
| | Diet | 1 | 2010 | 1213 | 0.010 |
Why?
| | Diabetes Insipidus | 1 | 1982 | 7 | 0.010 |
Why?
| | Risk | 1 | 1985 | 854 | 0.010 |
Why?
| | Lymphoma | 1 | 1983 | 196 | 0.010 |
Why?
| | Pancreatectomy | 1 | 1984 | 241 | 0.010 |
Why?
| | Hemoglobin A | 1 | 1982 | 22 | 0.010 |
Why?
| | Adenoma, Chromophobe | 1 | 1981 | 1 | 0.010 |
Why?
| | Patient Compliance | 1 | 2006 | 565 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1986 | 175 | 0.010 |
Why?
| | Desipramine | 1 | 1981 | 10 | 0.010 |
Why?
| | Mitral Valve Prolapse | 1 | 1981 | 9 | 0.010 |
Why?
| | Tomography, X-Ray | 1 | 1981 | 4 | 0.010 |
Why?
| | Alcoholic Intoxication | 1 | 1982 | 63 | 0.010 |
Why?
| | Motivation | 1 | 2006 | 546 | 0.010 |
Why?
| | Thyroid Function Tests | 1 | 1981 | 14 | 0.010 |
Why?
| | Prevalence | 1 | 2008 | 2564 | 0.010 |
Why?
| | Parotid Gland | 1 | 1980 | 22 | 0.010 |
Why?
| | Triiodothyronine | 1 | 1981 | 44 | 0.010 |
Why?
| | Survival Rate | 1 | 2005 | 1877 | 0.010 |
Why?
| | Hyperphagia | 1 | 1980 | 34 | 0.010 |
Why?
| | Apolipoprotein C-II | 1 | 1980 | 1 | 0.010 |
Why?
| | Food | 1 | 1982 | 157 | 0.010 |
Why?
| | Apolipoprotein C-III | 1 | 1980 | 13 | 0.010 |
Why?
| | Gonadal Steroid Hormones | 1 | 2002 | 131 | 0.010 |
Why?
| | Eating | 1 | 1983 | 369 | 0.010 |
Why?
| | Duodenum | 2 | 1977 | 75 | 0.010 |
Why?
| | Creatinine | 1 | 1982 | 491 | 0.010 |
Why?
| | Infarction | 1 | 1979 | 10 | 0.010 |
Why?
| | Apolipoproteins E | 1 | 1980 | 77 | 0.010 |
Why?
| | Pseudomonas Infections | 1 | 1982 | 221 | 0.010 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 1982 | 206 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1979 | 42 | 0.010 |
Why?
| | Lipolysis | 1 | 1979 | 41 | 0.010 |
Why?
| | Spinal Cord Diseases | 1 | 1979 | 41 | 0.010 |
Why?
| | Clofibrate | 1 | 1979 | 4 | 0.010 |
Why?
| | Cerebral Arteries | 1 | 1979 | 60 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1985 | 1367 | 0.010 |
Why?
| | Exercise | 1 | 2010 | 1925 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 1985 | 898 | 0.010 |
Why?
| | Radiography | 1 | 1981 | 798 | 0.010 |
Why?
| | Feeding and Eating Disorders | 1 | 1980 | 147 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1981 | 317 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 7133 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 1997 | 11 | 0.010 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 1997 | 31 | 0.010 |
Why?
| | Heparin | 1 | 1979 | 253 | 0.010 |
Why?
| | Ambulatory Care | 1 | 1982 | 504 | 0.010 |
Why?
| | Depressive Disorder | 1 | 1981 | 366 | 0.010 |
Why?
| | Secretin | 1 | 1977 | 5 | 0.010 |
Why?
| | Rats | 2 | 1984 | 5500 | 0.010 |
Why?
| | Methods | 1 | 1977 | 64 | 0.010 |
Why?
| | Bile | 1 | 1977 | 35 | 0.010 |
Why?
| | Bilirubin | 1 | 1977 | 96 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1977 | 77 | 0.010 |
Why?
| | Starch | 1 | 1976 | 22 | 0.010 |
Why?
| | Hypercholesterolemia | 1 | 1997 | 102 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2002 | 737 | 0.010 |
Why?
| | Sodium | 1 | 1977 | 206 | 0.010 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 1996 | 28 | 0.010 |
Why?
| | Hematocrit | 1 | 1976 | 93 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2005 | 4897 | 0.010 |
Why?
| | Tetany | 1 | 1976 | 3 | 0.010 |
Why?
| | Erythrocytes | 1 | 1981 | 672 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 3240 | 0.010 |
Why?
| | Evaluation Studies as Topic | 2 | 1987 | 173 | 0.010 |
Why?
| | Magnesium Sulfate | 1 | 1976 | 18 | 0.010 |
Why?
| | Calcification, Physiologic | 1 | 1976 | 34 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 1996 | 159 | 0.010 |
Why?
| | Cholangiography | 1 | 1975 | 17 | 0.010 |
Why?
| | Erythrocyte Count | 1 | 1975 | 19 | 0.010 |
Why?
| | Radioisotopes | 1 | 1975 | 31 | 0.010 |
Why?
| | Common Bile Duct | 1 | 1975 | 17 | 0.010 |
Why?
| | Bone Diseases | 1 | 1976 | 57 | 0.010 |
Why?
| | Selenium | 1 | 1975 | 36 | 0.010 |
Why?
| | Metabolic Clearance Rate | 2 | 1986 | 118 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 1996 | 387 | 0.010 |
Why?
| | Exons | 1 | 1996 | 342 | 0.010 |
Why?
| | Laparotomy | 1 | 1975 | 106 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1975 | 160 | 0.010 |
Why?
| | Inflammation | 1 | 2005 | 2736 | 0.010 |
Why?
| | Cardiomegaly | 1 | 1976 | 172 | 0.010 |
Why?
| | Iron | 1 | 1976 | 288 | 0.010 |
Why?
| | Leukocytes | 1 | 1996 | 304 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1975 | 326 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1984 | 4063 | 0.010 |
Why?
| | Pituitary Function Tests | 1 | 1993 | 3 | 0.010 |
Why?
| | Orbit | 1 | 1993 | 57 | 0.010 |
Why?
| | Pituitary Gland | 1 | 1993 | 148 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 2 | 1982 | 12 | 0.010 |
Why?
| | Vitamin D | 1 | 1976 | 384 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2142 | 0.010 |
Why?
| | Aging | 1 | 2002 | 1776 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1991 | 38 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2832 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 1997 | 901 | 0.010 |
Why?
| | Child | 3 | 1996 | 20883 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 1982 | 2142 | 0.010 |
Why?
| | Biopsy | 1 | 1993 | 1097 | 0.010 |
Why?
| | Diabetic Ketoacidosis | 1 | 1991 | 197 | 0.000 |
Why?
| | Liver | 2 | 1986 | 1839 | 0.000 |
Why?
| | Random Allocation | 1 | 1987 | 346 | 0.000 |
Why?
| | Bread | 1 | 1986 | 4 | 0.000 |
Why?
| | Danazol | 1 | 1985 | 2 | 0.000 |
Why?
| | Bromocriptine | 1 | 1985 | 29 | 0.000 |
Why?
| | Menstruation | 1 | 1985 | 44 | 0.000 |
Why?
| | Pyridoxine | 1 | 1985 | 32 | 0.000 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1985 | 80 | 0.000 |
Why?
| | Child, Preschool | 1 | 1979 | 10517 | 0.000 |
Why?
| | False Negative Reactions | 1 | 1984 | 53 | 0.000 |
Why?
| | Proinsulin | 1 | 1984 | 52 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 7086 | 0.000 |
Why?
| | Postoperative Complications | 1 | 1976 | 2483 | 0.000 |
Why?
| | Psychotherapy | 1 | 1985 | 157 | 0.000 |
Why?
| | Progesterone | 1 | 1985 | 245 | 0.000 |
Why?
| | Antidepressive Agents | 1 | 1985 | 228 | 0.000 |
Why?
| | Digestive System | 1 | 1983 | 29 | 0.000 |
Why?
| | Estrogens | 1 | 1985 | 347 | 0.000 |
Why?
| | Catecholamines | 1 | 1983 | 97 | 0.000 |
Why?
| | Exophthalmos | 1 | 1982 | 17 | 0.000 |
Why?
| | Chlorpropamide | 1 | 1982 | 1 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1984 | 1085 | 0.000 |
Why?
| | Kinetics | 1 | 1986 | 1642 | 0.000 |
Why?
| | Substance Withdrawal Syndrome | 1 | 1984 | 176 | 0.000 |
Why?
| | Calcitonin | 1 | 1982 | 27 | 0.000 |
Why?
| | Thyroidectomy | 1 | 1982 | 87 | 0.000 |
Why?
| | Magnetic Resonance Imaging | 1 | 1993 | 3408 | 0.000 |
Why?
| | Isotope Labeling | 1 | 1981 | 74 | 0.000 |
Why?
| | Coronary Circulation | 1 | 1981 | 138 | 0.000 |
Why?
| | Propranolol | 1 | 1981 | 50 | 0.000 |
Why?
| | Alkalosis | 1 | 1980 | 2 | 0.000 |
Why?
| | Amylases | 1 | 1980 | 17 | 0.000 |
Why?
| | Microscopy, Electron | 1 | 1981 | 426 | 0.000 |
Why?
| | Anorexia Nervosa | 1 | 1982 | 84 | 0.000 |
Why?
| | Hypertrophy | 1 | 1980 | 121 | 0.000 |
Why?
| | Islets of Langerhans | 1 | 1986 | 791 | 0.000 |
Why?
| | Indicators and Reagents | 1 | 1979 | 109 | 0.000 |
Why?
| | Testosterone | 1 | 1982 | 372 | 0.000 |
Why?
| | Gels | 1 | 1979 | 82 | 0.000 |
Why?
| | Heterozygote | 1 | 1979 | 272 | 0.000 |
Why?
| | Pedigree | 1 | 1979 | 487 | 0.000 |
Why?
| | Heart | 1 | 1981 | 637 | 0.000 |
Why?
| | Anemia, Hypochromic | 1 | 1976 | 4 | 0.000 |
Why?
| | Iron Radioisotopes | 1 | 1976 | 3 | 0.000 |
Why?
| | Depression, Chemical | 1 | 1976 | 22 | 0.000 |
Why?
| | Pica | 1 | 1976 | 5 | 0.000 |
Why?
| | Kidney | 1 | 1984 | 1385 | 0.000 |
Why?
| | Depression | 1 | 1985 | 1307 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1976 | 544 | 0.000 |
Why?
| | Genetic Variation | 1 | 1979 | 937 | 0.000 |
Why?
|
|
Falko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|